Slough, United Kingdom

Andrew John Kenny



 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Andrew John Kenny

Introduction

Andrew John Kenny is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of methods for obtaining antibodies. With a total of 3 patents to his name, his work has had a considerable impact on the industry.

Latest Patents

One of his latest patents is a process for obtaining antibodies. This patent describes a method for the manufacture of recombinant antibody molecules. The process involves culturing a host cell sample transformed with an expression vector encoding a recombinant antibody molecule. After adding an extraction buffer to the sample, it is subjected to a heat treatment step. The pH of the sample is detected after the addition of the extraction buffer and is optionally adjusted to ensure that it remains between 6 and 9 prior to the heat treatment step. This innovative approach enhances the efficiency of antibody production.

Career Highlights

Throughout his career, Andrew has worked with several prominent companies, including UCB Biopharma Srl and UCB Biopharma Sprl. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of biotechnology.

Collaborations

Andrew has collaborated with notable professionals in his field, including Jean-Pascal Pierre Bilgischer and Philip Jonathan Bassett. These collaborations have further enriched his work and expanded the scope of his innovations.

Conclusion

Andrew John Kenny's contributions to the field of biotechnology, particularly in antibody production, showcase his innovative spirit and dedication to advancing science. His patents and collaborations reflect a commitment to excellence and a drive to improve biotechnological processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…